Amyloidosis UK

Registered charity 1183624 · accounts filings on the Charity Commission register · also known as UK ATTR AMYLOIDOSIS PATIENTS' ASSOCIATION (UKATPA)

a) providing information, support and advice to people living with the Condition, their families and carers; b) advocating to ensure that every person has timely and effective diagnosis, treatment and care of the Condition;c) working closely with all stakeholders to facilitate the availability of effective treatments for the Condition. d) funding and supporting research to advance scientif

Objects

THE OBJECTS OF THE CIO ARE THE RELIEF OF SICKNESS AND THE PRESERVATION AND PROTECTION OF GOOD HEALTH AMONG PEOPLE IN THE UNITED KINGDOM LIVING WITH THE MEDICAL CONDITION ATTR AMYLOIDOSIS (KNOWN AS THE ‘CONDITION’) IN PARTICULAR BUT NOT EXCLUSIVELY BY:A) PROVIDING INFORMATION, SUPPORT AND ADVICE TO PEOPLE LIVING WITH THE CONDITION, THEIR FAMILIES AND CARERS;B) ADVOCATING TO ENSURE THAT EVERY PERSON HAS TIMELY AND EFFECTIVE DIAGNOSIS, TREATMENT AND CARE OF THE CONDITION;C) WORKING CLOSELY WITH ALL STAKEHOLDERS TO FACILITATE THE AVAILABILITY OF EFFECTIVE TREATMENTS FOR THE CONDITION.D) FUNDING AND SUPPORTING RESEARCH TO ADVANCE SCIENTIFIC UNDERSTANDING OF THE CONDITION AND ITS EFFECTIVE TREATMENT AND TO PUBLISH THE USEFUL RESULTS THEREOF FOR THE PUBLIC BENEFIT.

The charity’s charitable objects and area of benefit, quoted from its governing document as held on the Charity Commission register.

Causes: General Charitable Purposes · The Advancement Of Health Or Saving Of Lives · Grant history (this charity is a funder) · website · Get email alerts

Registered contact address: Waverley, South East, England (from the postcode on the register)

Latest income
£105k
Latest spending
£54k
Registered
2019
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that Amyloidosis UK generated total income of £105,228 and incurred total expenditure of £52,485, resulting in a surplus of £52,742 for the year ending 31/03/2025. The bank balance at year-end was £73,866.46, with no difference from the bank statement. The independent examiner confirmed that no material matters came to their attention that would cause them to believe the accounts were not prepared in accordance with the Charities Act 2011.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Accounts independently examined (not a full audit). Discloses 4 of 6 completeness components.

Policies the charity declares

In its annual return the charity told the Commission that it has the policies listed below. This is self-declared: it is not verified by the Commission or by this site, and it is not evidence of how a policy works in practice.

From the charity’s annual return (Part A, self-declared)

Answers and figures the charity gave in Part A of its annual return to the Charity Commission. They are self-declared: not verified by the Commission or by this site. Only positive answers and figures are listed; items not listed are simply not shown.

Self-declared on the annual return for the financial year ending 31/03/2025

  • Volunteers: 1

Self-declared on the annual return for the financial year ending 31/03/2024

  • Volunteers: 2

Self-declared on the annual return for the financial year ending 31/03/2023

  • Volunteers: 1

Source: this charity’s annual returns on the Charity Commission register.

Public fundraising profile: JustGiving — Amyloidosis UK (matched by registered charity number).

Public profiles (found on the charity’s own website): facebook · instagram

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Ireland · Northern Ireland · Scotland · Throughout England And Wales

Income and spending

Financial year endIncomeSpending
31/03/2025£105k£54k
31/03/2024£2k£18k
31/03/2023£4k£16k
31/03/2022£33k£31k
31/03/2021£31k£10k

Common questions

Is Amyloidosis UK financially healthy?

Per its FY2025 accounts: The accounts state that Amyloidosis UK generated total income of £105,228 and incurred total expenditure of £52,485, resulting in a surplus of £52,742 for the year ending 31/03/2025. The bank balance at year-end was £73,866.46, with no difference from the bank statement. The independent examiner confirmed that no material matters came to their attention that would cause them to believe the accounts were not prepared in accordance with the Charities Act 2011. Its FY2025 accounts were independently examined.

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with MYOSITIS UK.

Side by side with its peers

CharityIncomeTop pay bandStaff >£60kReserves vs policyFundraising costGoing concern
Amyloidosis UK£105k—0unclear—no doubt
MYOSITIS UK FY2025£140k—0unclear—no doubt
SARCOIDOSISUK FY2025£185k—0unclear—no doubt
THYROID UK FY2025£103k—0above—no doubt
ENDOMETRIOSIS UK FY2025£1.5m——unclear—no doubt
MLD UK FY2025£28k—0unclear—no doubt

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.